Wed, Aug 27, 2014, 10:59 AM EDT - U.S. Markets close in 5 hrs 1 mins


% | $
Quotes you view appear here for quick access.

Crosstex Energy, Inc. Message Board

spresidente 6 posts  |  Last Activity: Aug 17, 2014 12:45 AM Member since: Mar 29, 2008
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to


    by operacionsecuestro Aug 17, 2014 12:26 AM
    spresidente spresidente Aug 17, 2014 12:45 AM Flag

    Thanks operacion

  • spresidente by spresidente Jul 18, 2014 1:49 PM Flag

    Common and preferred shares in Fannie Mae and Freddie Mac rose this week after a legal ruling in favor of plaintiffs suing the government, but analysts say investors in the federally controlled mortgage-finance giants may not be any better off in the long run.

    On Wednesday Judge Margaret Sweeney in the U.S. Court of Federal Claims ordered that the discovery process in Fairholme Funds’ suit against the government can proceed.

    “The proper approach is for a court to examine the factual underpinnings and legal contentions presented by the complaint, in order to determine whether the exercise of its jurisdiction is proper,” Sweeney wrote.

    Common shares of Fannie FNMA and Freddie FMCC rose almost 9% and 10%, respectively, on Wednesday. Meanwhile, the most heavily traded preferred series of Fannie FNMAS and Freddie FMCKJ – these series are less liquid than the common shares and tend to be held by long-term investors — rose more than 2% and 3%, respectively.

    Fairholme, a major Fannie and Freddie investor, is suing over the government’s 2012 amendment to its bailout agreement that forces Fannie and Freddie to send all of their profit to the Treasury Department, thereby preventing investors such as Fairholme from receiving dividends. U.S. lawmakers have offered several proposals to wind down Fannie and Freddie, but are likely leaving thorny issues over shareholder compensation to the courts.

    While Sweeney’s decision is helpful for Fairholme, it wasn’t entirely unexpected and is far from a final ruling in investors’ favor, analysts at Keefe, Bruyette & Woods, a New York-based investment bank, wrote in a research note.

    “Courts usually err towards allowing more discovery rather than less and we thought the government’s claim of privilege to not disclose some documents was overly broad and unlikely to prevail in court,” KBW analysts wrote. “We remain skeptical that Fairholme will win its argument that the government has illegally seized the plaintiff’s private propert

    Sentiment: Strong Buy

  • Reply to


    by emanuel3 Jul 11, 2014 10:30 AM
    spresidente spresidente Jul 11, 2014 2:13 PM Flag

    The first few days of recreational sales in Washington State were a resounding success by most measures.

    The handful of shops that opened this week reported brisk business, national media coverage was largely favorable and consumers were on their best behavior – painting a positive picture of the industry.

    But the rollout of recreational sales wasn’t exactly smooth, and overall demand might not be as big as it seems.

  • Though the latest settlement relieves SunTrust of a legal overhang, the company continues to face other litigations pertaining to its malpractices in the pre-crisis period. The DOJ is still investigating fraudulent activities related to the sale of risky mortgage loans to the Government-sponsored enterprises, Fannie Mae (FNMA) and Freddie Mac (FMCC). SunTrust’s role in the U.S. Treasury Department mortgage-modification program is under scrutiny as well.

    Other Wall Street biggies embroiled in similar hassles include JPMorgan Chase & Co. (JPM), Bank of America Corporation, Citigroup Inc. and Morgan Stanley.

    Sentiment: Strong Buy

  • May 27, 2014 Letter From Henry Jan
    Dear Shareholders:

    Running a company related to the medical cannabis business is not like running any other kind of business. Dispensary owners and growers fear being raided by the US Government every single day they operate. Anyone who is really running a business in the #$%$ space is taking a risk. And it requires building a great deal of trust with those folks if you are to do business with them like we do as consultants to their business.

    As many know, with risks, there are rewards. Positioning is everything. I am a fan of gaining market share through investing and acquiring. Integrating other successful brands and creating the ultimate cannabis platform has always been my focus. A vertically and horizontally integrated business is what we are building. From advising on the grow process and facilities and developing the best products and brands to patient management and ordering platforms, we are positioning ourselves into becoming one of the best cannabis-related services business around.

    I am excited about our future. As regulations loosen up and more and more states begin to legalize medical cannabis, the infrastructure we have began developing will already be in place. We are now positioned. This is what we have been building over the past year and I thank you for being on this ride with us.

37.60-1.80(-4.57%)Mar 7 4:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.